CME/CE Accredited Session
Sponsored by Industry
Click For Session Details
Session Times Listed in ET
Ty J. Gluckman, MD, FACC, FAHA | Charles Vega, MD, FAAFP | Daniel A. Solomon, MD
This pandemic required communication among specialists and primary care. In this COVID-19 panel, faculty will team up to discuss the most pressing and frequently asked questions about this disease and its complications.
Medical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS), Providence Heart Institute, Providence St. Joseph Health, Portland, OR
Health Sciences Clinical Professor, UC Irvine Department of Family Medicine, Assistant Dean for Culture and Community Education, UC Irvine School of Medicine Director, UC Irvine Program in Medical Education for the Latino Community, Irvine, CA
Associate Physician, Division of Infectious Diseases, Brigham and Women's Hospital, Instructor of Medicine,, Harvard Medical School, Boston, MA
Early Action in HCC: Supporting the Patient Journey in Primary Care
Amit Singal, MD, MS | Ghassan Abou-Alfa, MD, MBA
Although hepatocellular carcinoma (HCC) screening can improve survival for patients, it is underused in clinical practice. Join two faculty experts as they discuss the urgency for early identification of HCC in primary care, and learn about the changing epidemiology of HCC and how primary care providers can support patients during their journey. This program also features patient/caregiver videos and interactive Q&A sessions.
Professor of Medicine, Willis C. Maddrey Chair in Liver Disease, Chair of Hepatology, Medical Directory of Liver Tumor Program, UT Southwestern Medical Center, Dallas, TX
Attending Physician, Memorial Sloan-Kettering Cancer Center, Professor of Medicine, Weill Medical College, Cornell University, New York, NY
Supported by an educational grant from Genentech, a member of the Roche Group
Addressing Low Detection of Chronic Kidney Disease in At-Risk Patients
Jennifer Ennis, MD, FACP
Chronic kidney disease (CKD) screening and early detection helps improve patient outcomes; however only 4 out of 5 at-risk adult patients in the U.S. are being fully tested per recommended guidelines. Join Labcorp and the National Kidney Foundation (NKF) leaders as they discuss a study that supports testing at-risk patients, particularly those with diabetes and hypertension. Additionally, you will hear new recommendations from the NKF-American Society of Nephrology Task Force on re-assessing the inclusion of race in diagnosing CKD.
On this Webinar you will learn about:
Medical Director, Clinical and Digital Solutions, Labcorp
Sponsored by Labcorp
COPD: What the Busy Clinician Needs to Know
Matthew Mintz, MD, FACP
This session will provide clinically relevant information regarding the management of patients with COPD and focuses on establishing a valid diagnosis, avoiding common pitfalls in assessment, reducing symptoms and preventing exacerbations.
Associate Clinical Professor of Medicine at, George Washington University School of Medicine & Health Sciences, Internal Medicine and Primary Care Physician,, Private Practice in Bethesda, Maryland
Sponsored by GlaxoSmithKline
Managing Myths and Misconceptions about Chronic Idiopathic Constipation and Irritable Bowel Syndrome with Constipation
Philip Schoenfeld, MD, MSEd, MSc
This activity will provide an evidence-based approach to the diagnosis and management of chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C), with minimal diagnostic testing. The faculty will describe evidence-based treatment guidelines and discuss the efficacy of over-the-counter and prescription agents prioritized within the guidelines. This will help you navigate the progress from patient education to diet plus over-the-counter agents to prescription agents.
Chief (Emeritus) - Gastroenterology Section, John D. Dingell VA Medical Center, Detroit, MI
Supported by Supported by an educational grant from AbbVie Inc. and Takeda Pharmaceuticals U.S.A., Inc..
Stewart J. Tepper, MD, FAHS | Merle Diamond, MD
The entire field of migraine is witnessing a profound and unprecedented transformation with new therapeutic options now available to address serious unmet medical needs and patient burden. The new options range from monoclonal antibodies (mAbs) targeting the CGRP ligand or receptor for migraine prevention, to a selective serotonin agonist, to oral CGRP-targeting agents (gepants) now approved for both preventive and acute treatment. These new advances are creating a vitality and excitement in the field not seen since the advent of triptans more than 2 decades ago.
Professor of Neurology, Geisel School of Medicine at Dartmouth, Director, Dartmouth Headache Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH
Clinical Assistant Professor, Department of Medicine, Rosalind Franklin Universty of Medicine and Science/Chicago Medical School, President and Managing Director, Diamond Headache Clinic, Chicago, IL
Supported by Biohaven Pharmaceuticals
Path To Diagnosis, Mapping Symptoms of Inflammatory Back Pain
Christopher Parker, DO
Sponsored by AbbVie
Treating Community-Acquired Bacterial Pneumonia (CABP): A Systemic Pleuromutilin Antibacterial in the Outpatient Setting
Christian Sandrock, MD, MPH, FCCP
Antimicrobial resistance, especially pneumococcal resistance to macrolide antibiotics, or potential safety concerns of commonly used antibiotics result in underserving certain patients with CABP. A systemic pleuromutilin antibacterial may be a treatment alternative for these underserved patients.
Director of Critical Care, UC Davis Health
Sponsored by Nabriva Therapeutics US, Inc.
What Primary Care Clinicians Need to Know About Alzheimer’s Disease: Early Diagnosis, Patient-Specific Management, and Care Collaboration
Richard S. Isaacson, MD | Katherine E. Galluzzi, DO, CMD, FACOFP
Are you frequently challenged by the task of early and accurate diagnosis of Alzheimer’s disease (AD) as a PCP? Are you keen to the possibility of collaboration with secondary care specialists to optimize early recognition and management of AD? Are you up to date on the latest developments and clinical pearls of Alzheimer’s research in order to tailor patient-specific approaches for AD? This live virtual meeting will examine these challenges and provide effective strategies to meet them head on.
This session will provide you with the latest information regarding the role of PCPs and their extended care team in early diagnosis of AD, effective methods to address racial and ethnic barriers to dementia-related care, and important clinical pearls to encourage collaboration among PCPs and secondary care specialists. In addition, learn the intricacies surrounding patient-specific management considerations, as well as the role of recently approved and emerging disease-modifying therapies for the management of AD.
Director, Center for Brain Health, Director, Alzheimer’s Prevention Clinic, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, Adjunct Associate Professor of Neurology, Department of Neurology, Weill Cornell Medicine/NewYork-Presbyterian, New York City, NY
Professor and Chair, Department of Geriatrics, Director, Comprehensive Care , Philadelphia College of Osteopathic Medicine, Philadelphia, PA
Supported by Eisai
Martin J. Abrahamson, MD, FACP | Ty J. Gluckman, MD, FACC, FAHA | Lee A. Lindquist, MD, MPH, MBA
What do primary care providers need to know about diabetes, atrial fibrillation, and geriatric cancer screening? Join expert faculty as they review important questions they get asked about these topics!
Associate Professor of Medicine, Harvard Medical School, Director, Division of CME, Beth Israel Deaconess Medical Center, Boston, MA
Medical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS) , Providence Heart Institute, Providence St. Joseph Health , Portland, OR
Chief of Geriatrics, Northwestern University Feinberg School of Medicine, Chicago, IL
Rethinking the Role of Nebulization in the Maintenance Treatment of COPD
Ryan D. Reber, DO
Join us to learn about a maintenance therapy for the treatment of COPD.
Chief of Pulmonary and Critical Care Medicine, Medical Director, Intensive Care Unit , Paoli Hospital, Clinical Assistant Professor of Medicine, Sidney Kimmel Medical College of Thomas Jefferson University
Sponsored by Viatris and Theravance Biopharma